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also studied. LV end-systolic and end-diastolic pressure-volume relation- 
ships (ESPVR & EDPVR) were measured using an intmvantdcular balloon. 
The data (means :t: SD, Rgure) indicate that, compared to normal he~ls, 
EsPVRs and EDPVRs of CHFc and CHFsx were shifted towards larger 
volumeS. There was a small leftward shift of the ESPVR of CHFEx and no 
significant change in EDPVR between CHF gmupe. 
Thus, El" blunted the rise in LVEDP, provided mild preservation of systOflo 
properflas but did not prevent he significant increase in chamber size (m- 
modeling) secondary to rapid pacing. The benefit.let effects of ET in CHF 
may relate more to peripheral than cardiac effects. 
~ DireCt Elfects o f  Chronic/~l-admnerglc Receptor 
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Francie G. Spinale, Wendy S. Johnson, Yinghua Wang, Zhongting Wang, 
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Chronic .8-receptar blod~de ~Block) has been reported to improve symp- 
toms and survival in patients wLth CHR However, whether the mechanisms 
for the effects of pBlock in CHF are due to modulating chronotropy, inotmpy, 
or both remains unknown, in order to address this issue, LV and isolated 
myocyte (MYO) function were examined with chronic/]Block in a rapid pac- 
ing model of CHF; and thereby eliminate potential chmnotropic effects of 
~Block. LV function (fractional shortening; FS, %, end-diastolic dimension; 
EDD, am) was measured in 3 groups of 6 pigs each: CHF: 3 wks pacing at 
240 bpm, CHF/pBIock;3 wks rapid pace and/3block (25 mg atennlol/BID at 
days 14-21 of pacing), CON: sham controls. This time of/3Block was chosen 
since cetecholamices are persistently elevated by day 14 in this modal of 
CHF. Isolated LV MYO Percent (PER, %) and velocity of shortening (MY- 
OVEL,/~m/s) were examined at baseline (BASE) and following p-receptor 
stimulation with iSoprotarenol (ISO, 25 nM). 
LVFS LVEDD MYO-PER MYO-VEL 
BASE ISO BASE leo 
CON 354-1 3.54.0.1 4.54-0.1 11.04.0.4 514-1 1794-8 
CHF 12±1" 5.4:L-0.1" 2.24.0.1" 4.1:L-0.2" 314-1" 824-5" 
CHF//~Block 174-3" 5.34-0.2" 2.7:L-0.1 *+ 4.9:L-0.1 *+ 334-1" 834-3, 
*p .¢ 0.05 vs (;ON; +p < 0.05 vs CHF 
Chronic~SBlock during pacing CHF had no sign~cant effects on LV function. 
MYO shortening percent increased with/]Black and was not due to increased 
MYO velocity, but rather to prolonged contraction duration (525:1: 5*+ms) 
compared to CHF and CON (469 ± 9 and 473:1:4 ms). Summary: In a model 
of CHF due to a chronic rapid heart rate, #Stock had minimal effects on LV 
and MYO function, These unique results suggest hat a mechanism for the 
effects of #-bloCkade obsswed in patients with CHF is due to chronotrepic 
modulation. 
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Human failing (F) myocardium Is characterized by abnormal [Ca~+]i handling 
~ nd deficient in tracellular cAMP. To investigate whether the abnormal [Ca2+]j 
andflag may De caused by altered sarcoplasmlo retk;ulum (SR) Ca 2+ re- 
uptake, we studied Ca z+ uplake, using the fluorescent Ca 2+ indicator FURA- 
2, in SR homogsnates from left vantdcias of nonfailing (NF, n = 7) and F (n 
= 14, 7 dilated & 7 Ischemio cardiomyopathy) explanted hearts. To examine 
whether stimulation of SR Ca 2+ uptake by cAMP and protein kinese A (PKA) 
is altered in F, we examined the effects of cAMP and PKA on SR Ca 2+ uptake 
in NF and F SR homagsnetes. 
l '  
",p'~O.01 compared to NF 
We conclude that: 1) SR Ca 2+ uptake is reduced in F, 2) CAMP & PKA 
am less pOtent in stimulating SR Ca 2+ uptake in F as compared to NF. 
The reduced SR Ca 2+ uptnko in F may result from alterations in the cAMP 
dependent phesphorylation cascade in F myocardium. 
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Recent investigations have demonstrated intrinsic skeletal muScle metabolic 
abnormalities in potlents (LOTS) with chronic heart failure (CHF). To disflnguish 
between the effects of impaired oxidation and reduction in muscle mass 
and/or metabolic efficiency, a detailed bioasergedc analysis was applied to 
data obtained by S~p magnetic resonance spectroscopy during asrubic ex- 
ercise and recovery in 40 male pta with CHF (EF: 23 ± 1.4%, NYHA I-  
IV). Results from 26 studies of forearm finger muscle flexion, 20 studies of 
gastrocnemius contraction and 6 of both were compared with age-matched 
normal controls, Twenty-two pts underwent exercise training of forearm (10 
pts) or gastrocoemius (12 pts). Changes in pH and phoephocreatine con- 
centretion during aerobic exercise and reCOvery were used to calculate the 
maximum rate of oxidative ATP synthesis and the "effective muscle mass; 
which combines true exercising muscle mass and metabolic efficiency (work 
done per ATP hydrolysed). In flexor digitorom supedicialis muscle there was 
a 30% decrease in oxidative capacity and a 45% decrease in metabefic effi- 
ciency. Increased ADP concentration during exercise permitted near-normal 
oxidative ATP synthesis, and so the increased phosphocraatine depletion 
and intracellular acidosis during exercise were due predominantly to do- 
creased metabolic efficienCy with consequent increase in glycoganciysis. 
Rasuifs were similar in gastrecnemius muscle, with a 25% decrease in 
oxidative capacity and a 6(P,~, decrease in metabolic efficiency. Beneficial ef- 
fects of exercise training on the flexor digiforum supsrficiaiis response were 
mainly due to improvement in oxidative capacity while in gastrecnemius both 
oxidative capacity and metabolic efficiency were improved by training. In 
conclusion, skeletal muscle metabolic abnormalities in CHF result more from 
the decrease in metabolic efficiency than from the (nevertheless ignificant) 
reduced mitechondrial oxidative capacity. Both abnormalities result in an in- 
creased activation of glycogen phosphovylase, and both may be improved 
by exercise training, 
~ Inhibit ion by Calcium Antagonism o f  Circulating 
and Rei;ai Endothelin In Experimental Congestive 
Heart Failure 
Chi-Ming Wei, Michihisa Jougasaki, Andreas I_uchner, Danyi Zhang, X. 
Charles Oat, John C. Bumett, Jr.. Mayo Clinic, Rochester. MN 
Endcthalin (E'r) is a i~otent vasoconstrictor and sodium regulating peptide 
whose tissue and plasma concentrations are increased in congestive heart 
failure (CHF) and which may mediate its vasoconstrictor and sodium rag- 
ulatory actions secondary to an increase in intraceflular calcium. Secondly, 
calcium influx may augment ET synthesis. While felodlpine, a dihydropyri- 
dine calcium channel antagonist, is effective in reducing vascular esistance 
in states of generalized vasoconstriction, the actions of felodipine in CHF 
on cimutating El" and local tissue ET remain undefined. The current stud- 
ies were designed to determine the modulating actions of the faledipine (n 
= 6, 40 ms/day oral, 7 days) in an experimental model of CHF produced 
by chronic thoracic inferior vena ceval constriction (TIVCC) compared with 
normal (n = 7) and TIVCC alone dogs (n == 7) in which in TIVCC circulating 
and renal El" are markedly increased. We hypothesized that felodiplne woald 
decrease circulating ET and renal ET. Plasma ET was significantly increased 
in TIVCC compared to normals (26 :E 0.5 vs 12 4- 0.7 pg/ml, p < (~.05) and 
was markedly decreased by falodipine treatment compared to TIVCC {14 
:t: 3 vs 26 ± 0.5 Wml, p ,: 0.05). Renal ET immunohiatochemicat staining 
demonstrated ET presence in normal kidney which was markedly increased 
in the TIVCC in both renal cortex and medulla. With feledipine treatment, 
both renal cortical and medullary ET were markedly decreased compared to 
TIVCC alone (stain score: 0.3:1:0,1 vs 1.5:1: 0.4, p < 0.05). In the faledipine 
+ TIVCC group, cardiovascular hemodynamlco also was road~edly improved 
compared to TIVCC (systemic vascular resistance: 27 :t: 2 vs 44 4- 3 RU, 
p < 0.05; pulmonary vascular resistance: 3.3 :t: 0.1 vs 5.7 =1:0.4 RU, p < 
0.05; cardiac output: 2.9 ~: 0,2 vs 1.7:1:0.1 IJmin, p < 0.05). This study 
demonstrates important modulating inhibitory actions of calcium antagonism 
with falodipine in this expedmantal model of CHF upon circulating and local 
renal ET. 
